Clinical Microbiology Market Size Share and Industry Outlook to 2028

SKU: DM2608 | Last Updated On: Dec 31 2021 | No. of Pages: 180 | Available Formats

> Global Clinical Microbiology Market is Expected to reach a high CAGR of 6.2% By 2028: DataM Intelligence

Global Clinical Microbiology Market is segmented By Product Type (Reagents, Laboratory Instruments, Automated Culture Systems), By Application (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021 - 2028

 

Market Overview

The Global "Clinical Microbiology Market" is expected to grow at a high CAGR of 6.2% during the forecasting period (2021 - 2028).

Clinical microbiology focuses on all aspects of patient infections from testing samples to identifying bacterial, viral, fungal, and parasitic agents that are contributing to the infectious process, determining the susceptibility of microorganisms to various antimicrobial agents, and reporting the results to healthcare providers.

The adaptation of microbiological techniques to the study of the etiological agents of infectious disease. Clinical microbiology determines the nature of the infectious disease and tests the ability of various antibiotics to inhibit or kill the isolated microorganisms. In addition to bacteriology, a contemporary clinical microbiologist is responsible for a wide range of microscopic and cultural studies in mycology, parasitology, and virology. The clinical microbiology is often the most competent person available to determine the nature and extent of hospital-acquired infections, as well as public-health problems that affect both the hospital and the community.

*Source: DataM Intelligence Analysis 

Market Dynamics:

The market is driven is the rising infectious diseases that are primarily diagnosed using clinical tests. According to the Centers for Disease Control and Prevention (CDC), around 9,421 new cases of tuberculosis, 51,455 new cases of salmonella, 33,461 new cases of Lyme disease, and 433 new cases of meningococcal disease were registered in the U.S. in 2014.

Similarly, according to the American Cancer Society, around 1,688,780 new cases of cancer were diagnosed in the U.S. in 2017. Thus, the high prevalence of diseases where clinical tests are used as one of the major diagnostic tools is expected to augment market growth in the future. Sudden outbreaks of Ebola, Zika, and other contagious pathogens are also contributing to the rising prevalence of infectious diseases. As per an article published in the Journal of Clinical Microbiology, there is a shortage of trained and skilled professionals in medical and microbiological laboratories for processing and interpreting samples and specimens. Moreover, there has been a steep decline in the number of medical laboratory training programs and students graduating from such programs in the U.S.

As high-income countries are stepping up their pursuit of countering hospital-acquired infections, middle- and low-income countries are recognizing the threat. The introduction of automated systems and innovative designs is expected to intensify market competition and change market dynamics over the forecast period. This factor is driving the growth of the market in the forecast period.

The World Health Organization (WHO) is particularly active in countries such as Ethiopia, Burkina Faso, Nigeria, Algeria, and Senegal, where the occurrence of HAIs ranged between 2.5% and 14.8%. This has led to increased demand for HAI diagnostics in these countries. Countries such as India, Sri Lanka, Pakistan, and Bhutan are also actively participating in HAI awareness programs. India and China are projected to be the main countries driving demand for HAI diagnostics instruments and tests in the future. This factor is also driving the growth of the market in the forecast period.

Similarly, factors like the consolidation of diagnostic laboratory chains and the increase in public awareness are driving the growth of the market. The emerging countries are expected to outperform the U.S. and European countries. This is mainly due to the increase in the major hospital chains opening new centers in major cities as well as an increase in government expenditure.

However, Clinical microbiology testing procedures are not adequately reimbursed across several countries such as India, China, and other emerging countries in the Middle East and Africa, which have a high target patient population base. This is a major factor that limits the preference for clinical microbiology products among patients and healthcare professionals. This directly affects the adoption of premium-priced clinical microbiology products, thereby negatively affecting their market growth in the forecast period.

The recent outbreak of the COVID-19 pandemic is negatively affecting the growth of the market as the laboratories are busy with the COVID-19 test which has halted all other tests. This factor will hinder the growth of the market in the forecast period.

Segment Analysis

The global clinical microbiology market is segmented based on product type by laboratory instruments which are further sub-segmented into incubators, gram strainers, bacterial colony counters, autoclave sterilizers, petri dish fillers, and automated culture systems which is further sub-segmented into microbiology analyzers, molecular diagnostic instruments, microscopes, mass spectrometers, and reagents. The reagents segment held the largest market share. Factors such as the higher cost of specialized kits and constant repeat purchase are expected to drive the segment over the forecast period. A reagent s a substance or compound added to a system to cause a chemical reaction, or added to test if a reaction occurs. The importance of reagents will continue to outstrip supplies in many places as the race for safe and effective vaccines and treatment. A reagent may be used to tell whether or not a specific chemical substance is present by causing a reaction to occur with it.

The laboratory instruments segment is expected to have a positive market. Laboratories require a variety of equipment and consumables to perform tests and research activities. These are found in different types of laboratories such as research labs, clinical diagnostic labs, pathology labs, microbiology labs, educational labs, etc. to carry out research, scientific experiments, and execute analyses of different scientific materials.

It is estimated that the laboratory instrument segment is expected to witness significant growth over the forecast period, owing to technological advancements in the field of laboratory equipment, an increase in the number of clinical diagnostic procedures, and a rise in private & public healthcare investments. Besides, favorable insurance policies related to laboratory equipment further supplement the market growth. Furthermore, an increase in research related to life science and biotechnology boosts the laboratory instruments segment

Government and private research firms are taking initiatives in the research and development activities in context to diagnose and treat several diseases worldwide through innovative technologies like specialty instruments. For instance, in 2016, Cancer Research UK spend US$ 583 million on cancer research to develop new treatments and to optimize existing cancer treatment. The amount spent was US$ 51 million on clinical trials study, US$ 50 million on research into new drugs, and US$ 23 million on research to identify possible causes of cancer. This factor is further driving the growth of the market.

Increasing chronic diseases such as chronic respiratory diseases, cardiovascular diseases, and diabetes, and increasing incidence of lifestyle diseases such as heart disease, obesity, atherosclerosis and hereditary diseases such as hemophilia, Down’s syndrome, cystic fibrosis, and sickle cell anemia are leading to the increasing demand of laboratory equipment to bring innovative technologies in the market. According to the World Health Organization (WHO), the non-communicable disease leads to cause 40 million deaths each year, which is equivalent to 70% of all deaths worldwide. Cardiovascular diseases account for most of NCD mortality (17.7 million) annually, followed by cancer (8.8 million), respiratory disease (3.9 million), and diabetes (1.6 million). Thus, these factors will drive the growth of the market in the forecast period.

**Source: DataM Intelligence Analysis

Further, the market is also classified based on application as respiratory diseases, bloodstream infections, gastrointestinal diseases, and others. The respiratory diseases segment is held the largest market share. The rise in prevalence of respiratory infectious diseases, such as Coronavirus diseases, MERS, chronic obstructive pulmonary disease, tuberculosis, pertussis, and influenza, is projected to drive the segment.

According to data published in January 2020, 2519 laboratory-conformed cases of Middle East respiratory syndrome (MERS), were reported, which includes 866 associated deaths globally. The majority of cases reported were from Saudi Arabia (2121 cases), including 788 related deaths with a higher fatality rate of 37.1%.

Moreover, the emergence of the COVID 19 pandemic has driven the segment. According to statistics, as of April 2020, there were around 3.45 million cases of COVID-19 globally, which drives the respiratory diseases segment. This factor will drive the growth of the market in the forecast period.

**Source: DataM Intelligence Analysis

Geographical Presentation

By region, the global clinical microbiology market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global surgical glue market and is expected to grow at the highest CAGR during the forecast period due to an increase in the burden of COVID-19, well-developed health care infrastructure, and increasing prevalence of chronic obstructive pulmonary diseases, flu diseases, whooping cough, and other respiratory infections. This is anticipated to augment the Respiratory infectious disease treatment market in the region. COPD is considered to be the third-leading cause of death in the U.S., and the fourth-leading cause of death across the world. According to an article published on Very well Health, COPD affects around 11 million people in the U.S. and occurs in people over the age of 40. These statistics drive the demand for the treatment of respiratory infectious diseases. This factor will drive the growth of the market in the region.

Europe was the second-largest market for respiratory infectious diseases followed by the Asia Pacific, owing to the rising prevalence of COPD disease in the region. For instance, according to the European Respiratory Nurses Association (ERNA), 259,000 people die of COPD each year in the EU. Moreover, rising cases of COVID 19 in Italy, Spain, the U.K., and other countries across Europe are boosting the need for treatment of respiratory infectious diseases across the region.

The market in the Asia Pacific is anticipated to expand at a rapid pace during the forecast period, owing to the COVID-19 pandemic and key players involved in manufacturing generic drugs for the treatment of the disease. This factor will drive the growth of the market in the region.

**Source: DataM Intelligence Analysis

Competitive Analysis

The global clinical microbiology market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market bioMérieux SA, Danaher Corporation, Becton, Dickinson and Company, Abbott Laboratories, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche AG, Bruker Corporation, Hologic, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc. are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, and product diversification strategies for holding their position in the market.

The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to expand their presence and meet the rising demand for clinical microbiology across the globe.

For instance, in 2017, bioMérieux held the leading position in the global clinical microbiology market. The company has a robust product portfolio and a strong geographical presence in more than 150 countries across the world. To maintain its leadership position in the market, the company has been focusing on R&D activities and new product launches.

In 2017, Hologic (US) collaborated with Seegene Inc. (South Korea) to develop and supply highly multiplexed real-time PCR reagents and assays for Hologic's Panther Fusion platform.

Why Purchase the Report?

  • Visualize the composition of the global clinical microbiology market products in terms of product type, and application and highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the global clinical microbiology market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global clinical microbiology market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

**The global clinical microbiology market report will provide access to approximately 38 market data tables, 52 figures, and 200 pages

Target Audience2022

  • Industry Investors/Investment Bankers
  • Suppliers/Buyers
  • Education & Research Institutes
  • Manufacturers
  • Research Professionals
  • Emerging Companies
  • Distributors

Trending Topics

Clinical Chemistry Market

 

 

Table of Contents

  1. Global Clinical Microbiology Market Methodology and Scope
    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Global Clinical Microbiology Market – Market Definition and Overview
  3. Global Clinical Microbiology Market – Executive Summary
    1. Market Snippet by Product Type
    2. Market Snippet by Application
    3. Market Snippet by Region
  4. Global Clinical Microbiology Market Dynamics
    1. Market Impacting Factors
      1. Drivers
        1. A rise in infectious diseases
        2. Increase in public awareness
      2. Restraints
        1. Clinical microbiology testing procedures are not adequately reimbursed across a number of countries
    2. Impact Analysis
    3. Opportunity
  5. Global Clinical Microbiology Market – Industry Analysis
    1. Porter's Five Forces Analysis
    2. Supply Chain Analysis
    3. Regulatory Analysis
    4. Pricing Analysis
    5. Product Analysis
    6. Post Sales Services Analysis
  6. Global Clinical Microbiology Market – By Product Type
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    3. Market Attractiveness Index, By Product Type
      1. Reagents *
        1. Introduction
        2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
      2. Laboratory Instruments
        1. Incubators,
        2. Gram strainers
        3. Bacterial colony counters
        4.  Autoclave sterilizers
        5. Petri dish fillers
      3. Automated Culture Systems
        1. Microbiology Analyzers
        2.  Molecular diagnostic instruments
        3.  Microscopes
        4.  Mass Spectrometers
  7. Global Clinical Microbiology Market – By Application
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    3. Market Attractiveness Index, By Application
      1. Respiratory Diseases
        1. Introduction
        2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
      2. Bloodstream Infections,
      3. Gastrointestinal Diseases
      4. Others
  8. Global Clinical Microbiology Market - By Region
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    3. Market Attractiveness Index, By Region
    4. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. The U.S.
        2. Canada
        3. Mexico
    5. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. The U.K.
        3. France
        4. Rest of Europe
    6. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    7. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    8. The Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  9.  Global Clinical Microbiology Market Competitive Landscape
    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  10. Global Clinical Microbiology Market Company Profiles  
    1. bioMérieux SA*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Developments
      4. Financial Overview
    2. Danaher Corporation, Becton
    3.  Dickinson and Company
    4. Abbott Laboratories
    5. Bio-Rad Laboratories, Inc
    6. , F. Hoffmann-La Roche AG
    7. Bruker Corporation
    8. Hologic, Inc.
    9.  QIAGEN N.V.
    10. Thermo Fisher Scientific Inc.  (*List is not exhaustive)
  11. Global Clinical Microbiology Market – Premium Insights
  12. Global Clinical Microbiology Market – DataM
    1. Appendix
    2. About Us and Services
    3. Contact Us

 

List of Tables & Figures

List of Tables 

Table 01 Global Clinical Microbiology Market Value, By Product Type, 2018,2022 & 2028 ($ Million)

Table 02 Global Clinical Microbiology Market Value, By Application, 2018,2022 & 2028 ($ Million)

Million)

Table 03 Global Clinical Microbiology Market Value, By Region, 2018,2022 & 2028 ($ Million)

Table 04 Global Clinical Microbiology Market Value, By Product Type, 2018,2022 & 2028 ($ Million)

Table 05 Global Clinical Microbiology Market Value, By Product Type, 2018-2028 ($ Million)

Table 06 Global Clinical Microbiology Market Value, By Application, 2018,2022 & 2028 ($ Million)

Table 07 Global Clinical Microbiology Market Value, By Application, 2018-2028 ($ Million)

Table 08 Global Clinical Microbiology Market Value, By Region, 2018,2022 & 2028 ($ Million)

Table 09 Global Clinical Microbiology Market Value, By Region, 2018-2028 ($ Million)

Table 10 North America Clinical Microbiology Market Value, By Product Type, 2018-2028 ($ Million)

Table 11 North America Clinical Microbiology Market Value, By Application, 2018-2028 ($ Million)

Table 12 North America Clinical Microbiology Market Value, By Country, 2018-2028 ($ Million)

Table 13 South America Clinical Microbiology Market Value, By Product Type, 2018-2028 ($ Million)

Table 14 South America Clinical Microbiology Market Value, By Application, 2018-2028 ($ Million)

Million)

Table 15 South America Clinical Microbiology Market Value, By Country, 2018-2028 ($ Million)

Table 16 Europe Clinical Microbiology Market Value, By Product Type, 2018-2028 ($ Million)

Table 17 Europe Clinical Microbiology Market Value, By Application, 2018-2028 ($ Million)

Table 18 Europe Clinical Microbiology Market Value, By Country, 2018-2028 ($ Million)

Table 19 Asia-Pacific Clinical Microbiology Market Value, By Product Type, 2018-2028 ($ Million)

Table 20 Asia-Pacific Clinical Microbiology Market Value, By Application, 2018-2028 ($ Million)

Table 21 Asia-Pacific Clinical Microbiology Market Value, By Country, 2018-2028 ($ Million)

Table 21 Middle East & Africa Clinical Microbiology Market Value, By Product Type, 2018-2028 ($ Million)

Table 22 Middle East & Africa Clinical Microbiology Market Value, By Application, 2018-2028 ($ Million)

Table 23 bioMérieux SA: Overview

Table 24 bioMérieux SA: Product Portfolio

Table 25 bioMérieux SA: Key Developments

Table 26 Danaher Corporation, Becton: Overview

Table 27 Danaher Corporation, Becton: Product Portfolio

Table 28 Danaher Corporation, Becton: Key Developments

Table 29 Dickinson and Company: Overview

Table 30 Dickinson and Company: Product Portfolio

Table 31 Dickinson and Company: Key Developments

Table 32 Abbott Laboratories: Overview

Table 33 Abbott Laboratories: Product Portfolio

Table 34 Abbott Laboratories: Key Developments

Table 35 Bio-Rad Laboratories, Inc: Overview

Table 36 Bio-Rad Laboratories, Inc: Product Portfolio

Table 37 Bio-Rad Laboratories, Inc: Key Developments

Table 38 F. Hoffmann-La Roche AG: Overview

Table 39 F. Hoffmann-La Roche AG: Product Portfolio

Table 40 F. Hoffmann-La Roche AG: Key Developments

Table 41 Bruker Corporation: Overview

Table 42 Bruker Corporation: Product Portfolio

Table 43 Bruker Corporation: Key Developments

Table 44 Hologic, Inc.: Overview

Table 45 Hologic, Inc.: Product Portfolio

Table 46 Hologic, Inc.: Key Developments

Table 47 QIAGEN N.V.: Overview

Table 48 QIAGEN N.V.: Product Portfolio

Table 49 QIAGEN N.V.: Key Developments

Table 50 Thermo Fisher Scientific Inc.: Overview

Table 51 Thermo Fisher Scientific Inc.: Product Portfolio

Table 52 Thermo Fisher Scientific Inc.: Key Developments

 

List of Figures

Figure 01 Global Clinical Microbiology Market Share, By Product Type, 2018 & 2028 (%)

Figure 02 Global Clinical Microbiology Market Share, By Application, 2018 & 2028 (%)

Figure 03 Global Clinical Microbiology Market Share, By Region, 2018 & 2028 (%)

Figure 04 Global Clinical Microbiology Market Value, 2018-2028 ($ Million)

Figure 05 Global Clinical Microbiology Market Y-o-Y Growth, By Product Type, 2018-2028 (%)

Figure 06 Reagents Laboratory Instrument Automated Culture Systems

: Global Clinical Microbiology Market Value, 2018-2028 ($ Million)

Figure 07 Global Clinical Microbiology Market Y-o-Y Growth, By Application, 2018-2028 (%)

Figure 08 Respiratory Diseases Bloodstream Infections Gastrointestinal Diseases Others: Global Clinical Microbiology Market Value, 2018-2028 ($ Million)

Figure 09 Global Clinical Microbiology Market Y-o-Y Growth, By Region, 2018-2028 (%)

Figure 10 North America Clinical Microbiology Market Value, 2018-2028 ($ Million)

Figure 11 North America Clinical Microbiology Market Share, By Product Type, 2018 & 2028 (%)

Figure 12 North America Clinical Microbiology Market Share, By Application, 2018 & 2028 (%)

 

Figure 13 North America Clinical Microbiology Market Share, By Country, 2018 & 2028 (%)

Figure 14 South America Clinical Microbiology Market Value, 2018-2028 ($ Million)

Figure 15 South America Clinical Microbiology Market Share, By Product Type, 2018 & 2028 (%)

Figure 16 South America Clinical Microbiology Market Share, By Application, 2018 & 2028 (%)

Figure 17 South America Clinical Microbiology Market Share, By Country, 2018 & 2028 (%)

Figure 18 Europe Clinical Microbiology Market Value, 2018-2028 ($ Million)

Figure 19 Europe Clinical Microbiology Market Share, By Product Type, 2018 & 2028 (%)

Figure 20 Europe Clinical Microbiology Market Share, By Application, 2018 & 2028 (%)

Figure 21 Europe Clinical Microbiology Market Share, By Country, 2018 & 2028 (%)

Figure 22 Asia-Pacific Clinical Microbiology Market Value, 2018-2028 ($ Million)

Figure 23 Asia-Pacific Clinical Microbiology Market Share, By Product Type, 2018 & 2028 (%)

Figure 24 Asia-Pacific Clinical Microbiology Market Share, By Application, 2018 & 2028 (%)

Figure 25 Asia-Pacific Clinical Microbiology Market Share, By Country, 2018 & 2028 (%)

Figure 26 Middle East & Africa Clinical Microbiology Market Value, 2018-2028 ($ Million)

Figure 27 Middle East & Africa Clinical Microbiology Market Share, By Product Type, 2018 & 2028 (%)

Figure 28 Middle East & Africa Clinical Microbiology Market Share, By Application, 2018 & 2028 (%)

Figure 29 bioMérieux SA: Financials

Figure 30 Danaher Corporation, Becton: Financials

Figure 31 Dickinson and Company: Financials

Figure 32 Abbott Laboratories: Financials

Figure 33 Bio-Rad Laboratories, Inc: Financials

Figure 34 F. Hoffmann-La Roche AG: Financials

Figure 35 Bruker Corporation: Financials

Figure 36 Hologic, Inc.: Financials

Figure 37 QIAGEN N.V.: Financials

Figure 38 Thermo Fisher Scientific Inc.: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest